Search

Search Results

• COVID-19 myocarditis

  Reinaldo B. Bestetti, Rosemary Furlan-Daniel, Luciano P. Pereira

  2024-03-28

  https://doi.org/10.4081/cardio.2024.21

  2825

  PDF: 339

  HTML: 14

• Intervention options: depression and cardiovascular disease during COVID-19

  Eirini Flouda, Athena Stefanatou, Tinia Apergi

  2023-11-28

  https://doi.org/10.4081/cardio.2023.5

  1966

  pdf: 322

  HTML: 32

• Dyslipidemia and stroke-related mortality in the United States: a nationwide analysis for 2010-2020

  Muhammad Muneeb Ur Rehman, Iliyan Mithani, Muhammad Sameer Arshad, Syed Raza Shah, Wolfram Doehner, Anandita Kulkarni

  2025-12-31

  https://doi.org/10.4081/cardio.2025.90

  422

  PDF: 136

  Supplementary: 38

  HTML: 33

• Iron supplementation in heart failure and iron deficiency: does it help?

  Laibah Arshad Khan, Syed Sarmad Javaid, Javed Butler

  2025-09-30

  https://doi.org/10.4081/cardio.2025.82

  721

  PDF: 440

  HTML: 72

• Sex-based differences in characteristics, management, and outcomes in heart failure with reduced ejection fraction

  Christian Basile, Stefan D. Anker, Gianluigi Savarese

  2025-06-30

  https://doi.org/10.4081/cardio.2025.73

  943

  PDF: 308

  Supplementary: 185

  Appendix: 135

  HTML: 89

• Effect of metformin and empagliflozin on myocardial function in insulin-resistant patients with heart failure: rationale and design of the METRIS-HF-DZHK18 Trial

  Wolfram Doehner, Tim Friede, Frank Edelmann, Ulf Landmesser, Sebastian Winkler, Burkert Pieske, Fabian Knebel, Sebastian Kelle, Diethelm Tschöpe, Antje Meyer, Nadja Jauert, Marius Placzek, Jeanette Schulz-Menger, Stephan von Haehling, Stefan D. Anker

  2025-12-31

  https://doi.org/10.4081/cardio.2025.89

  353

  PDF: 113

  Appendix: 33

  HTML: 11

• Iron deficiency in heart failure with preserved ejection fraction: rationale and design of the FAIR-HFpEF trial

  Stephan von Haehling, Wolfram Doehner, Ruben Evertz, Tania Garfias-Veitl, Monika Diek, Mahir Karakas, Ralf Birkemeyer, Gerasimos Fillippatos, Piotr Ponikowski, Michael Böhm, Tim Friede, Stefan D. Anker

  2023-12-27

  https://doi.org/10.4081/cardio.2023.15

  2784

  pdf: 753

  HTML: 47

• Large language models to write scientific manuscripts: to be considered but not trusted

  Christian Basile, Stefan D. Anker, Gianluigi Savarese

  2025-06-30

  https://doi.org/10.4081/cardio.2025.74

  888

  PDF: 319

  HTML: 13

• Sex differences in clinical characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction

  Christian Basile, Stefan D. Anker, Gianluigi Savarese

  2025-07-16

  https://doi.org/10.4081/cardio.2025.76

  921

  PDF: 262

  Supplementary: 187

  Appendix: 133

  HTML: 59

• Beyond trial neutrality: treatment discontinuation and the hidden signal in SPIRIT-HF trial

  Viana Copeland, Andrew J.S. Coats

  2026-03-31

  https://doi.org/10.4081/cardio.2026.100

  591

  PDF: 201

  HTML: 104

• Evaluating serum galectin-3 binding protein as a diagnostic and prognostic biomarker in pulmonary arterial hypertension: a comparative study

  Arif Albulushi, Lama S. Alfehaid, Mosaad Alhussein, Amr Youssef

  2024-12-30

  https://doi.org/10.4081/cardio.2024.50

  1913

  PDF: 601

  HTML: 20